期刊文献+

阿尔兹海默病中tau蛋白磷酸化调节 被引量:6

The regulation of phosphorylation of tau protein in Alzheimer’s disease
原文传递
导出
摘要 细胞内高度磷酸化tau蛋白形成的神经纤维缠结是阿尔兹海默病的主要病理特征之一。过度磷酸化的tau蛋白将引起细胞内微管的紊乱,从而造成神经元突触连接的丢失。Tau蛋白的磷酸化受到多种因素的影响,这些因素的失常将会导致tau蛋白的异常磷酸化。Tau蛋白的基本功能和结构、翻译后的主要修饰以及蛋白激酶和磷酸酯酶的调节,在阿尔兹海默病理以及预防治疗中发挥重要作用。 The intracellular neurofibrillary tangle leaded to by the hyperphosphorylated tau protein is one of the major pathological characters of the Alzheimer's disease (AD). The hyperphosphorylated tau protein will make the microtube instable. Finally, the synapse between the neurons will be lost. There are many factors regulate the phosphorylation of tau protein, and the dysfunction of these factors may lead to the abnormal phosphorylation oftau protein. The basic structure and function oftau protein, the post-translational modifcation of tau protein as well as the function of the kinase and the phosphatase during phosphorylation regulation, play key roles on pathology, prevention and treatment of AD.
出处 《生命的化学》 CAS CSCD 2013年第1期6-13,共8页 Chemistry of Life
基金 国家自然科学基金面上项目(31071512) 北京市优秀人才培养资助项目(2012D005022000006)
关键词 TAU蛋白 TAU蛋白磷酸化 阿尔兹海默病 tau protein phosphorylation oftau Alzheimer's disease (AD)
  • 相关文献

参考文献51

  • 1Weiner MW, Aisen PS, Jack CR Jr, et al. The Alzffdimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement, 2010, 6:202-211 e207.
  • 2Hardy J. A hundred years of Alzheimer's disease ? research. Neuron, 2006, 52:3-13.
  • 3Mandelkow E, von Bergen M, Biemat J, et al. Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol, 2007, 17:83-90.
  • 4Adams S J, DeTure MA, McBride M, et al. Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One, 2010, 5:el0810.
  • 5Buee L, Bussiere T, Buee-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev, 2000, 33:95-130.
  • 6Kopke E, Tung YC, Shaikh S, et al. Microtubule- associated protein tau. Abnormal phospliorylation of a non-paired helical filament pool in Alzheimer disease, d Biol Chem, 1993, 268:24374-24384.
  • 7Andreasen N, Vanmechelen E, Vanderstichele H, et al. Cerebrospinal fluid levels of total-tau, phospho-tau and AD 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment Acta Neurol Scand Suppl, 2003, 179:47-51.
  • 8Mitchell AJ. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J Neurol Neurosurg Psychiatry, 2009, 80:966-975.
  • 9Andreasen N, Minthon L, Clarberg A, et al. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology, 1999, 53:1488-1494.
  • 10Scheurich A, Urban PP, Koch-Khoury N, et al. CSF phospho-tau is independent of age, cognitive status and gender of neurological patients. J Neurol, 2010, 257: 609-614.

二级参考文献20

  • 1Goode BL, Chau M, Denis PE, et al. Structural and Functional Differences between 3-repeat and 4-repeat Tau Isoforms.Implications for normal tau function and the onset of neurodegenetative disease [J]. J Biol Chem, 2000, 275 (49):38182-38189.
  • 2Hirokawa N, Shiomura Y, Okabe S, et al. Tau proteins: the molecular structure and mode of binding on microtubules [ J ]. J Cell Biol, 1988, 107(4): 1449-1459.
  • 3Gomez-Ramos A, Smith MA, Perry G, et al. Tau phosphorylation and assembly[J]. Acta Neurobiol Exp (Wars), 2004, 64(1): 33-39.
  • 4Sengupta A, Kabat J, Novak M, et al. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules [ J ].Arch Biochem Biophys, 1998, 357(2): 299-309.
  • 5Seubert P, Mawal-Dewan M, Barbour R, et al. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau [J]. J Biol Chem, 1995, 270(32): 18917-18922.
  • 6Gotz J, Probst A, Spillantini MG, et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform [J]. EMBO J, 1995, 14(7):1304-1313.
  • 7Brion JP, Tremp G, Octave JN. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease [J]. Am J Pathol,1999, 154(1): 255-270.
  • 8Spittaels K, Van den Haute C, Van Dorpe J, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein[J]. Am J Pathol, 1999,155(6): 2153-2165.
  • 9Probst A, Gotz J, Wiederhold KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein [J].Acta Neuropathol (Berl), 2000, 99(5): 469-481.
  • 10Ishihara T, Hong M, Zhang B, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform [J]. Neuron, 1999, 24(3): 751-762.

共引文献6

同被引文献87

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部